Abstract

With its population of 167 million, Nigeria has the highest burden of sickle cell disease (SCD) in the world with birth prevalence of 2% and 0.05% in adults due to deaths in early childhood. Sickle cell disease is thus a major contributor to Nigeria’s "under five" mortality figures. Failure to pay attention to such a widespread condition in the population is slowing progress towards Nigeria’s achievement of the Millennial Development Goals (MDG) 3-5. Although the Federal Government set up six MDG Sickle Cell Centres in 2012 in six geopolitical zones and equipped them with variant newborn high performance liquid chromatography equipment, these centres are not carrying out newborn screening in a systematic and standardized way and the equipment is not being fully utilized. There is no universal screening of babies for SCD and identification at the primary care level. The care of SCD has been confined to tertiary health care centres with few dedicated sickle cell clinics. The average age of presentation at these centres is eight years, and there is no formal referral system of patients through the lower levels of care. In developed countries, major benefits in the health and survival of patients with SCD have been achieved through the implementation of a few highly effective evidence-based interventions. A community-based intervention program is described which will provide parents, caregivers, and health care workers at primary health centres and ward levels with basic health education to look after patients with SCD, recognize early warning signs of complications, and institute appropriate referral mechanism to the comprehensive centres where advanced medical care can be given as necessary.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call